113 related articles for article (PubMed ID: 10864)
1. The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant.
Strosberg AM
Arch Int Pharmacodyn Ther; 1976 Aug; 222(2):200-15. PubMed ID: 10864
[TBL] [Abstract][Full Text] [Related]
2. Circulatory effects of tazolol in experimental myocardial infarction.
Buckley HT; Strosberg AM; Harrison DC
Am J Cardiol; 1975 May; 35(5):619-25. PubMed ID: 235834
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
Hirohashi M; Takasuna K; Yamashita N; Tamura K
Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
[TBL] [Abstract][Full Text] [Related]
5. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocking and hemodynamic effects of ASL-8052.
Gorczynski RJ; Murthy VS; Hwang TF
J Cardiovasc Pharmacol; 1984; 6(6):1548-59. PubMed ID: 6084788
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog.
Yabuuchi Y; Yamashita S; Tei SS
J Pharmacol Exp Ther; 1977 Aug; 202(2):326-36. PubMed ID: 18598
[No Abstract] [Full Text] [Related]
9. Pharmacological studies of mabuterol, a new selective beta 2-stimulant. II: Effects on the cardiovascular system and smooth muscle organs.
Osada E; Murai T; Ishizaka Y; Sanai K
Arzneimittelforschung; 1984; 34(11A):1641-51. PubMed ID: 6152157
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular effects of 5-hydroxypropranolol (ORF 12592) in dogs.
Ram N; Bauer EW; Hesse UC; Heilman RD
Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):118-25. PubMed ID: 921395
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cholecystokinin (CCK-8) with agonist and antagonist of beta-adrenergic receptors in circulatory system of diabetic rats.
Wiśniewska RJ; Wiśniewski K
Pol J Pharmacol; 1996; 48(3):293-7. PubMed ID: 9112665
[TBL] [Abstract][Full Text] [Related]
12. Aortic peak flow velocity as an index of myocardial contractility in the conscious rat.
Dowell RT; Houdi AA
Methods Find Exp Clin Pharmacol; 1997 Oct; 19(8):533-9. PubMed ID: 9442476
[TBL] [Abstract][Full Text] [Related]
13. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
Lindner E
Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
[TBL] [Abstract][Full Text] [Related]
14. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
[TBL] [Abstract][Full Text] [Related]
15. [The effect of atenolol on contractility and hemodynamics of the infarcted heart in comparison to propranolol and practolol (author's transl)].
Stephan K; Meesmann W; Bischoff KO; Hübner H; Geigenmüller L; Diesch J
Arzneimittelforschung; 1975 Nov; 25(11):1770-6. PubMed ID: 1243085
[TBL] [Abstract][Full Text] [Related]
16. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
Nishimura T; Kita S; Abiko Y
J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular pharmacology of the antibiotic ionophore Ro 2-2985 (X537A).
Osborne MW; Wenger JJ; Zanko MT
J Pharmacol Exp Ther; 1977 Jan; 200(1):195-206. PubMed ID: 833757
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic antagonism of beta adrenergic blockade in dogs. II. Hemodynamic effects of simultaneous intravenous infusion of isoproterenol and dopamine during chronic propranolol administration.
Spotnitz HM; Avery GJ; Rose EA; Benvenisty AI; Malm JR; Hoffman BF
J Thorac Cardiovasc Surg; 1980 Jan; 79(1):103-8. PubMed ID: 6243164
[TBL] [Abstract][Full Text] [Related]
19. Does myocardial adenyl cyclase represent the cardiac beta-receptor?
Strosberg AM; Waterbury LD
Proc West Pharmacol Soc; 1976; 19():466-9. PubMed ID: 11505
[No Abstract] [Full Text] [Related]
20. Hemodynamic effects of arotinolol in anesthetized dogs and its affinities for adrenoceptors in vitro.
Hashimoto H; Asano M; Hayashi T; Oguro K; Takiguchi Y; Nakashima M
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):23-34. PubMed ID: 6202253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
